Safety of everolimus by treatment duration in patients with advanced renal cell cancer in an expanded access program

Alfonsus J.M. Van Den Eertwegh, Pierre Karakiewicz, Sevil Bavbek, Sun Young Rha, Sergio Bracarda, Amit Bahl, Yen Chuan Ou, Dennis Kim, Ashok Panneerselvam, Oezlem Anak, Viktor Grünwald

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Safety of everolimus by treatment duration in patients with advanced renal cell cancer in an expanded access program'. Together they form a unique fingerprint.

Medicine & Life Sciences